NORTH CHICAGO, Ill.
Jan. 4, 2013
/PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, today declared the Company's first quarterly cash dividend of
The cash dividend is payable
Feb. 15, 2013
to stockholders of record at the close of business on
Jan. 15, 2013
AbbVie began trading on the New York Stock Exchange (NYSE) on
Jan. 2, 2013
under the symbol "ABBV" and was also added to the S&P 500 Index.
AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
AbbVie aims to help patients live healthier lives and collaborate on sustainable healthcare solutions. In 2013, AbbVie will employ approximately 21,000 people worldwide and market medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit
on Twitter or view careers on our